Sexual Health / side effects and safety / Last reviewed 2026-04-04

Gonadorelin Side Effects: Safety Signals and Warnings

Gonadorelin safety concerns are compound-specific. The main listed side effects are Injection site reactions, Headache, and Nausea. The main warning signals are Ovarian hyperstimulation syndrome monitoring required during pulsatile therapy, Not for use in patients with pituitary tumors, and Anaphylaxis rare but reported.

Read the full Gonadorelin guide Browse answer pages

Direct Answer

Gonadorelin is FDA-approved as a diagnostic agent for assessing hypothalamic-pituitary-gonadal axis function, with extensive clinical use in fertility workup. As a short-acting GnRH pulse used to stimulate LH/FSH secretion, it also has applications in hypogonadotropic hypogonadism treatment and fertility protocols. A well-validated compound with a real regulatory record.

Evidence grade
Level A
Research status
FDA Approved
Category
Sexual Health
Best for
HPA axis diagnostic testing, hypogonadotropic hypogonadism treatment, fertility protocol support, HPG axis research

Reported Side Effects

Warnings

Known or Plausible Interactions

Regulatory Context

FDA-approved prescription medication. Not a controlled substance. Available as Factrel (diagnostic) and Lutrepulse/Lutrelef (therapeutic).

Evidence Snapshot

Evidence gradeLevel A
Research statusFDA Approved
Best supported outcomesPituitary Function Assessment (Level A), Fertility Restoration (Level A), and LH/FSH Stimulation (Level A)
Primary citation count2
Last reviewed2026-04-04

Related Guides

How to Cite This Page

ExaminePeptides. "Gonadorelin Side Effects: Safety Signals and Warnings." Last reviewed 2026-04-04. https://examinepeptides.com/answers/gonadorelin-side-effects-safety/

This static answer page is built for fast indexing and direct citation. It summarizes the matching full evidence review and links back to primary sources where the source database includes them.